High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 194-197

  Di Fede, Gaetana ^a   Mansueto, Pasquale ^a   Pepe, Ilenia ^a   Rini, Giovam Battista ^a   Carmina, Enrico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

hirsultism; Hyperandrogenism; nonclassic adrenal hyperplasia; PCOS

Indexed keywords

HYDROXYPROGESTERONE; PRASTERONE SULFATE; PROGESTERONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ADRENAL HYPERPLASIA; ADULT; ANOVULATION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION; PREVALENCE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RETROSPECTIVE STUDY; STEROID 21 MONOOXYGENASE DEFICIENCY; SYMPTOM; TESTOSTERONE BLOOD LEVEL;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; FEMALE; HIRSUTISM; HUMANS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952542019     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.056     Document Type: Article

References (18)

1. Carmina E., and Lobo R.A. Hirsutism, alopecia and acne. In: Beckers K.L. (Ed). Principles and practice of endocrinology and metabolism. 3rd ed (2001), Lippincott Publishing, Philadelphia, PA 991-1008
2. Carmina E., and Lobo R.A. Polycystic ovary syndrome (PCOS), arguably the most common endocrinopathy, is associated with significant morbidity in women. J Clin Endocrinol Metab 84 (1999) 1897-1899
3. Martyn K.A., Chang R.J., Ehrmann D.A., Ibanez L., Lobo R.A., Rosenfield R.L., et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93 (2008) 1105-1120
4. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 140 (1981) 815-830
5. Carmina E., Stanczyk F., Chang L., Miles R.A., and Lobo R.A. The ratio of androstenedione: 11β-hydroxyandrostenedione is an important marker of adrenal androgen excess in women. Fertil Steril 58 (1992) 148-152
6. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 139 (1998) 421-423
7. Carmina E., and Lobo R.A. Ovarian suppression reduces clinical and endocrine expression of late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 62 (1994) 738-743
8. Balen A.H., Laven J.S., Tan S.L., and Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 (2003) 505-514
9. Carmina E., Orio F., Palomba S., Longo R.A., Lombardi G., and Lobo R.A. Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters. Fertil Steril 84 (2005) 413-419
10. Jonard S., Robert Y., and Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 20 (2005) 2893-2898
11. Carmina E., Rosato F., Jannì A., Rizzo M., and Longo R.A. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91 (2006) 2-6
12. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91 (2006) 4237-4245
13. Carmina E. The spectrum of androgen excess disorders. Fertil Steril 85 (2006) 1582-1585
14. Zawdaki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rationale approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific Publications, Boston, MA 377-384
15. Azziz R., Waggoner W.T., Ochoa T., Knochenauer E.S., and Boots L.R. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 70 (1998) 274-278
16. Carmina E., and Lobo R.A. Do hyperandrogenic women with normal menses have polycystic ovary syndrome?. Fertil Steril 71 (1999) 319-322
17. Knochenhauer E.S., Key T.J., Kahsar-Miller W., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the South Eastern USA: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
18. Carmina E., Longo R.A., Rini G.B., and Lobo R.A. Phenotypic variation in hyperandrogenic women influences the finding of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90 (2005) 2545-2549